In the mid-1990s, a transnational civil society campaign emerged to challenge Big Pharma over HIV/AIDS medicines patent protection. In 2001, the dispute crystallized into a dramatic media event as pharmaceutical companies sued the South African government over medicine patent laws. The South African lawsuit has been described as a “public relations disaster” for Big Pharma, and a turning point in HIV/AIDS medicines and intellectual property rights discourse. This article assesses these claims in relation to a corpus-assisted discourse analysis of 1,000 articles from U.S., U.K., and South African press outlets from 1997 to 2003. The study finds that a key discourse change to occur over this period was the elevation of generic HIV/AIDS medicines from an excluded criminal threat to a respected legitimate option. Given subsequent policy developments considerably increasing access to generic HIV/AIDS medicines in majority world countries, this article argues that the news media discourse change was a key transformative moment in addressing the global HIV/AIDS epidemic. The study also notes, however, that an antigeneric discourse persisted throughout the coverage, signifying the ongoing contestation of medicine patent protection that continues to characterize global HIV/AIDS medicines access.
AlexanderJeffrey C.JacobsRonald N.1998. “Mass Communication, Ritual and Civil Society.” In Media, Ritual and Identity, ed. LiebesTamarCurranJames, 23–41. London: Routledge.
2.
AngellMarcia. 2004. The Truth about Drug Companies: How They Deceive Us and What to Do about It. New York: Random House.
3.
AttaranAmirGillespie-WhiteLee. 2001. “Do Patents for Antiretroviral Drugs Constrain Access to AIDS Treatment in Africa?” Journal of the American Medical Association286 (15): 1886–92.
4.
BakerPaul. 2006. Using Corpora in Discourse Analysis. London: Continuum.
5.
BarnardDavid. 2002. “In the High Court of South Africa, Case No. 4138/98: The Global Politics of Access to Low-Cost AIDS Drugs in Poor Countries.” Kennedy Institute of Ethics Journal12 (2): 159–74.
6.
BennettW. LanceLawrenceRegina G.1995. “News Icons and the Mainstreaming of Social Change.” Journal of Communication45 (3): 20–39.
7.
BergerGuy. 2002. “Theorizing the Media-Democracy Relationship in Southern Africa.” Gazette: The International Journal for Communication Studies64 (1): 21–45.
8.
BondPatrick. 1999. “Globalization, Pharmaceutical Pricing, and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians.” International Journal of Health Services29 (4): 765–92.
9.
BoyleMichael P.McLeodDouglas M.ArmstrongCory L.2012. “Adherence to the Protest Paradigm: The Influence of Protest Goals and Tactics on News Coverage in U.S., and International Newspapers.” The International Journal of Press/Politics17 (2): 127–44.
ButlerJudith. 1993. Bodies that Matter. London: Routledge.
12.
ClementeConstantine L.1988. “A Pharmaceutical Industry Perspective.” In Intellectual Property Rights and Capital Formation in the Next Decade, ed. WalkerCharles EdwardBloomfieldMark A., 127–34. Lanham: University Press of America.
13.
CliftCharles. 2004. “The Development Impact of Rich Countries’ Policies: The Case of Intellectual Property Rights.” In Impact of Rich Countries’ Policies on Poor Countries: Towards a Level Playing Field in Development Cooperation, ed. PicciottoRobertWeavingRachel, 161–86. New Brunswick: Transaction.
14.
CorreaCarlos M.2007. Trade Related Aspects of Intellectual Property Rights: A Commentary on the TRIPS Agreement. Oxford: Oxford University Press.
15.
CottleSimon. 2006. Mediatized Conflict: New Developments in Media and Conflict Studies. Maidenhead, UK: Open University Press.
16.
CottleSimon. 2008. “Reporting Demonstrations: The Changing Media Politics of Dissent.” Media, Culture & Society30 (6): 853–72.
17.
CottleSimon. 2009. “Global Crises in the News: Staging Wars, Disasters and Climate Change.” International Journal of Communication3:494–516.
18.
CottleSimonNolanDavid. 2007. “Global Humanitarianism and the Changing Aid-Media Field.” Journalism Studies8 (6): 862–78.
19.
CPTech, Essential Action, Oxfam, Treatment Access Campaign, and Health GAP. 2001. “Comment on the Attaran/Gillespie-White and PhRMA Surveys of Patents on Antiretroviral Drugs in Africa.”http://www.cptech.org/ip/health/africa/dopatentsmatterinafrica.html (accessed March 11, 2011).
20.
DawkinsCedric E.2005. “First to Market: Issue Management Pacesetters and the Pharmaceutical Industry Response to AIDS in Africa.” Business & Society44 (3): 244–82.
21.
DerridaJacques. 1981. Positions. Chicago: University of Chicago Press.
22.
DrahosPeterBraithwaiteJohn. 2002. Information Feudalism: Who Owns the Knowledge Economy?London: Earthscan.
23.
DuguidAlison. 2007. “Soundbiters Bit: Contracted Dialogistic Space and the Textual Relations of the No. 10 Team Analysed through Corpus Assisted Discourse Studies.” In Discourse and Contemporary Social Change, ed. FaircloughNormanCorteseGiuseppinoArdizzonePotrizia, 73–94. New York: Peter Lang.
24.
FaulkSaskiaUsunierJean-Claude. 2009. AIDS and Business. New York: Routledge.
25.
FinlayA.2004. “Shaping the Conflict: Factors Influencing the Representation of Conflict around HIV/AIDS Policy in the South African Press.” Communicare23 (2): 68–93.
26.
ForbesDerekMalamMustaphaBoyd-BarrettOliver. 1998. “From Apartheid to Pluralism.” In The Globalization of News, ed. Boyd-BarrettOliverRantanenTerhi, 154–72. London: SAGE.
27.
FouriePieter J.2010. “The Past, Present and Future of South African Journalism Research, or: In Search of a Metatheory for South African Journalism Research.” Communication: South African Journal for Communication Theory and Research36 (2): 148–71.
28.
FoxHarold G.1947. Monopolies and Patents. Toronto, Ontario, Canada: University of Toronto Press.
29.
GarnierJean-Pierre. 2008. “Rebuilding the R&D Engine in Big Pharma.” Harvard Business Review86 (5): 68–76.
30.
GitlinTodd. 1980. The Whole World Is Watching: Mass Media in the Making and Unmaking of the New Left. Berkeley: University of California Press.
31.
HalbertDeborah J.2005. Resisting Intellectual Property. New York: Routledge.
32.
HallidayM. A. K.2004. An Introduction to Functional Grammar. 3rd ed.London: Arnold.
33.
HallinDaniel. 1986. The “Uncensored War”: The Media and Vietnam. Oxford: Oxford University Press.
34.
HallinDanielManciniPaolo. 2004. Comparing Media Systems: Three Models of Media and Politics. Cambridge: Cambridge University Press.
35.
HeywoodMark. 2001. “Debunking ‘Conglomo-Talk’: A Case Study of the Amicus Curiae as an Instrument for Advocacy, Investigation and Mobilisation.” Law, Democracy & Development5 (2): 133–62.
36.
KennedyCharles R.HarrisFrederick H.LordMichael. 2004. “Integrating Public Policy and Public Affairs in a Pharmaceutical Marketing Program: The AIDS Pandemic.” Journal of Public Policy & Marketing23 (2): 128–39.
37.
KlugHeinz. 2008. “Law, Politics, and Access to Essential Medicines in Developing Countries.” Politics & Society36 (2): 207–46.
38.
LaclauErnestoMouffeChantal. 1985. Hegemony and Socialist Strategy. London: Verso.
39.
LarkinBarbara. 1999. U.S. Government Efforts to Negotiate the Repeal, Termination, or Withdrawal of Article 15(c) of the South African Medicines and Related Substances Act of 1997. Washington, DC: Department of State.
40.
LawrenceRegina G.2000. The Politics of Force: Media and the Construction of Police Brutality. Berkeley: University of California Press.
41.
LeeChi-ChuanLiHongtaoLeeFrancis L. F.2011. “Symbolic Use of Decisive Events: Tiananmen as a News Icon in the Editorials of the Elite U.S. Press.” The International Journal of Press/Politics16 (3): 335–56.
42.
MachlupFritzPenroseEdith T.1950. “The Patent Controversy in the Nineteenth Century.” The Journal of Economic History10 (1): 1–29.
MatthewsDuncan. 2011. Intellectual Property, Human Rights and Development: The Role of NGOs and Social Movements. Cheltenham: Edward Elgar.
45.
MayneRuth. 2002. “The Global Campaign on Patents and Access to Medicines: An Oxfam Perspective.” In Global Intellectual Property Rights: Knowledge, Access and Development, ed. DrahosPeterMayneRuth, 244–58. New York: Palgrave Macmillan.
46.
McQuailDenis. 2000. McQuail’s Mass Communication Theory. 4th ed.London: Sage.
47.
Médicins Sans Frontières. 2011a. 10 Stories That Mattered in Access to Medicines in 2011. Geneva, Switzerland: Médicins Sans Frontières.
48.
Médicins Sans Frontières. 2011b. Untangling the Web of Antiretroviral Price Reductions. 14th ed.http://utw.msfaccess.org/downloads (accessed March 15, 2013).
49.
MouffeChantal. 2005. On the Political. New York: Routledge.
50.
OlesenThomas. 2006. “‘In the Court of Public Opinion’: Transnational Problem Construction in the HIV/AIDS Medicine Access Campaign, 1998-2001.” International Sociology21 (1): 5–30.
51.
PartingtonAlan. 2004. “Corpora and Discourse, a Most Congruous Beast.” In Corpora and Discourse, ed. PartingtonAlanMorleyJohnHaarmanLouanna, 11–20. Bern: Peter Lang.
ReisiglMartinWodakRuth. 2001. Discourse and Discrimination: Rhetorics of Racism and Anti-Semitism. London: SAGE.
55.
RichardsDonald G.2004. Intellectual Property Rights and Global Capitalism: The Political Economy of the TRIPS Agreement. London: M.E. Sharpe.
56.
RichardsonJohn E.2007. Analysing Newspapers: An Approach from Critical Discourse Analysis. New York: Palgrave Macmillan.
57.
RyanMichael P.1998. “The Function-Specific and Linkage-Bargain Diplomacy of International Intellectual Property Lawmaking.” University of Pennsylvania Journal of International Economic Law19 (2): 535–86.
58.
SantoroMichaelPaineLynn. 2003. “Pfizer: Global Protection of Intellectual Property (Harvard Business School Case Study No. 9-392-073).” In Managing International Trade and Investment, ed. SparD.London: Imperial College Press.
59.
SawyerEric. 2002. “An ACT UP Founder ‘Acts Up’ for Africa’s Access to AIDS.” In From ACT UP to the WTO: Urban Protest and Comsmunity Building in the Era of Globalization, ed. ShepardB.HaydukR., 88–102. New York: Verso.
60.
SchwartländerBernhardGrubbIanPerriënsJos. 2006. “The 10-Year Struggle to Provide Antiretroviral Treatment to People with HIV in the Developing World.” The Lancet368 (9534): 541–6.
61.
ScottMike. 2004. WordSmith Tools Version 4. Oxford: Oxford University Press.
62.
SellSusan K.2001. “TRIPS and the Access to Medicines Campaign.” Wisconsin International Law Journal20:481–522.
63.
SellSusan K.2003. Private Power, Public Law: The Globalization of Intellectual Property Rights. Cambridge: Cambridge University Press.
64.
ShadlenKenneth C.2004. “Patents and Pills, Power and Procedure: The North-South Politics of Public Health in the WTO.” Studies in Comparative International Development39 (3): 76–108.
65.
ShadlenKenneth C.2007. “The Political Economy of AIDS Treatment: Intellectual Property and the Transformation of Generic Supply.” International Studies Quarterly51:559–81.
66.
SobierajSarah. 2011. Soundbitten: The Perils of Media-Centered Political Activism. New York: New York University Press.
67.
SteinJo. 2003. “What’s News: Perspectives on HIV/AIDS Advocacy in the South African Print Media.” African Journal of AIDS Research2 (1): 75–83.
68.
StoreyGraham. 1951. Reuters’ Century 1851-1951. London: Max Parrish.
69.
Teer-TomaselliRuthWassermanHermanDe BeerArnold S.2007. “South Africa as a Regional Media Power.” In Media on the Move: Global Flow and Contra-Flow, ed. ThussuD. K., pp. 136–45. New York: Routledge.
70.
ThetelaPuleng. 2001. “Critique Discourses and Ideology in Newspaper Reports: A Discourse Analysis of the South African Press Reports on the 1998 SADC’s Military Intervention in Lesotho.” Discourse & Society12 (3): 347–70.
71.
’t HoenEllen. 2009. The Global Politics of Pharmaceutical Monopoly Power: Drug Patents, Access, Innovation and the Application of the WTO Doha Declaration on TRIPS and Public Health. Diemen, Netherlands: AMB.
72.
TraquinaNelson. 2004. “Theory Consolidation in the Study of Journalism: A Comparative Analysis of the News Coverage of the HIV/AIDS Issues in Four Countries.” Journalism5 (1): 97–116.
73.
Treatment Action Campaign. 2001. “Victory for Activists, People with HIV/AIDS and Poor People Everywhere!” Media Release, April19, 2001. http://www.cptech.org/ip/health/sa/TAC04192001.html (accessed March 23, 2013).
74.
von Schoen-AngererTidoFordNathanArkinstallJames. 2012. “Access to Medicines in Resource-Limited Settings: The End of a Golden Decade?” Global Advances in Health and Medicine1 (1): 52–59.
75.
WarnerMarkAttaranAmirFinstonSusanLoveJamesMallettRobert L.VisserCoenraad. 2002. “Panel I: AIDS Drugs and the Developing World: The Role of Patents in the Access of Medicines.” Fordham Intellectual Property Media and Entertainment Law Journal12:683–728.
76.
WeaverDavid A.ScaccoJoshua M.2013. “Revisiting the Protest Paradigm: The Tea Party as Filtered through Prime-Time Cable News.” The International Journal of Press/Politics18 (1): 61–84.
77.
WeissmanRobert. 1996. “Long, Strange Trips: The Pharmaceutical Industry Drive to Harmonize Global Intellectual Property Rules, and the Remaining WTO Legal Alternatives Available to Third World Countries.” University of Pennsylvania Journal of International Economic Law17:1069–125.
78.
WHO/UNAIDS. 2006. Progress on Global Access to HIV Antiretroviral Therapy: A Report on 3 by 5 and Beyond. Geneva: World Health Organization.
79.
WuH. Dennis. 1998. “Investigating the Determinants of International News Flow: A Meta-Analysis.” International Communication Gazette60 (6): 493.
